Treatment of Childhood Acute Lymphoblastic Leukemia
Authors:
- 1 January 2009
- journal article
- review article
- Published by Elsevier in Seminars in Hematology
- Vol. 46 (1) , 52-63
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95Blood, 2008
- Childhood cancers in Chennai, India, 1990–2001: Incidence and survivalInternational Journal of Cancer, 2008
- Long-Term Results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: Insight on the Prognostic Value of DNA Index in the Framework of Berlin-Frankfurt-Muenster–Based ChemotherapyJournal of Clinical Oncology, 2008
- Temporal trends in the incidence rate of childhood cancer in Germany 1987–2004International Journal of Cancer, 2007
- Trends in childhood cancer incidence in the U.S. (1992–2004)Cancer, 2007
- Childhood cancer epidemiology in low‐income countriesCancer, 2007
- Treatment of Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 2006
- BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991–1996)Leukemia, 2002
- Co-operative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92Leukemia, 2000
- Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995Leukemia, 2000